Gastroenterology specialists from McGovern Medical School and other physicians are gearing up for the 3rd Annual Gastroenterology and Hepatology Symposium, set for Feb. 8-9.
Registration is open for the upcoming 3rd Annual UTHealth Neurology Update Symposium, presented by the Department of Neurology at McGovern Medical School, set for Nov. 10.
Students, faculty, and members of the public interested in learning about the transformative changes in healthcare delivery for stroke and cerebrovascular disease are invited to attend Friday’s 10th Annual Yatsu Day Symposium, sponsored by the Institute for Stroke and Cerebrovascular Disease at McGovern Medical School.
Practicing otolaryngologists, as well as residents and fellows in otolaryngology training programs, and other health care providers are invited to a weekend in Texas Hill Country for the upcoming ENT Symposium set for April 28 and 29.
Registration for attendees and presentations are now open for the Center for Advanced Cardiopulmonary Therapies and Transplantation’s first annual Houston Shock Symposium, set to be held April 7 and 8.
The 2nd Annual UTHealth Neurology Update Symposium is now just a month away, with this year’s full-day CME accredited program focusing on topics like progressive, multiple sclerosis, Parkinson’s Disease and Alzheimer’s Disease.
While Texas has escaped the brunt of a U.S. opioid epidemic that has seen overdose deaths nearly quadruple since 1999, Houston-area health care providers and researchers are launching a new effort to explore solutions not only to America’s addiction to painkillers but growing concerns about the use of high-risk medications in the vulnerable geriatric population.
Physicians and healthcare professionals are invited to attend a one-day symposium, “Frontiers in Gastrointestinal and Liver Disease” sponsored by the Department of Internal Medicine at McGovern Medical School, Saturday, Feb. 11.
The Annual Symposium of the CPRIT Therapeutic Antibody Core will take place noon – 5:30 p.m., Thursday, Dec. 1. The symposium will showcase successful research programs that have worked closely with the antibody core for identifying, validating, and developing cancer antibody drugs.